| C5AR1 |
C5AR1, C5AR, C5R1: C5a anaphylatoxin chemotactic receptor |
ARRB2 |
IPI00027355 |
1.47 |
Evidence |
|
| FPR1 |
FPR1: fMet-Leu-Phe receptor |
ARRB2 |
IPI00027355 |
1.47 |
Evidence |
|
| AZU1 |
AZU1: Azurocidin precursor |
CAMP |
CAMP, CAP18, HSD26, FALL39: Cathelicidin antimicrobial peptide precursor |
1.47 |
Evidence |
|
| CTSG |
CTSG: Cathepsin G precursor |
CAMP |
CAMP, CAP18, HSD26, FALL39: Cathelicidin antimicrobial peptide precursor |
1.47 |
Evidence |
O
|
| HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
TAF6 |
TAF6, TAF2E, TAFII70: Transcription initiation factor TFIID subunit 6 |
1.467 |
Evidence |
|
| HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
TBP |
TBP, GTF2D1, TF2D, TFIID: TATA-box-binding protein |
1.467 |
Evidence |
|
| PES1 |
PES1: Pescadillo homolog 1 |
HIST1H2AG |
HIST1H2AG, H2AFP, HIST1H2AI, H2AFC, HIST1H2AK, H2AFD, HIST1H2AL, H2AFI, HIST1H2A |
1.467 |
Evidence |
|
| GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
SREBF2 |
IPI00478350 |
1.467 |
Evidence |
|
| U2AF1 |
U2AF1, U2AF35, U2AFBP: Splicing factor U2AF 35 kDa subunit |
IFI16 |
IPI00217474 |
1.467 |
Evidence |
|
| SFRS12 |
SFRS12, SRRP86: Splicing factor, arginine/serine-rich 12 |
EEF1A1 |
EEF1A1: Elongation factor 1-alpha |
1.467 |
Evidence |
|
| IL2RG |
IL2RG: Cytokine receptor common gamma chain precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
1.467 |
Evidence |
|
| HLA-C |
HLA-C, HLAC: HLA class I histocompatibility antigen, Cw-7 alpha chain precursor |
ARAF |
ARAF, ARAF1, PKS, PKS2: A-Raf proto-oncogene serine/threonine-protein kinase |
1.467 |
Evidence |
|
| PRKCZ |
PRKCZ, PKC2: Protein kinase C zeta type |
EFNB3 |
EFNB3, EPLG8, LERK8: Ephrin-B3 precursor |
1.465 |
Evidence |
|
| TGFBR1 |
TGFBR1: TGF-beta receptor type-1 precursor |
RAB35 |
RAB35, RAB1C, RAY: Ras-related protein Rab-35 |
1.465 |
Evidence |
|
| ACF |
ACF, ASP: APOBEC1 complementation factor |
TPR |
TPR: Nucleoprotein TPR |
1.462 |
Evidence |
|
| TACC3 |
TACC3, ERIC1: Transforming acidic coiled-coil-containing protein 3 |
CHC1 |
RCC1: RCC1-I (Fragment) |
1.46 |
Evidence |
|
| CTBP1 |
CTBP1, CTBP: C-terminal-binding protein 1 |
SREBF2 |
IPI00478350 |
1.46 |
Evidence |
|
| YWHAQ |
YWHAQ: 14-3-3 protein theta |
EIF5 |
EIF5: Eukaryotic translation initiation factor 5 |
1.46 |
Evidence |
|
| NCF1 |
Neutrophil cytosolic factor 1 variant (Fragment) |
CAP1 |
CAP1, CAP: Adenylyl cyclase-associated protein 1 |
1.46 |
Evidence |
|
| PFN1 |
PFN1: Profilin-1 |
CREBBP |
CREBBP, CBP: CREB-binding protein |
1.46 |
Evidence |
|
| SPINK1 |
SPINK1, PSTI: Pancreatic secretory trypsin inhibitor precursor |
SEL1L |
SEL1L, TSA305, UNQ128/PRO1063: Protein sel-1 homolog 1 precursor |
1.46 |
Evidence |
|
| RAD21 |
RAD21, HR21, KIAA0078, NXP1: Double-strand-break repair protein rad21 homolog |
VAV2 |
VAV2, RP11-153P4.1-003: Vav 2 oncogene |
1.46 |
Evidence |
|
| WASPIP |
IPI00552369 |
PECAM1 |
PECAM1: Platelet endothelial cell adhesion molecule precursor |
1.46 |
Evidence |
|
| ARPC5 |
ARPC5, ARC16: Actin-related protein 2/3 complex subunit 5 |
HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
1.46 |
Evidence |
|
| TUBA1 |
TUBA4A, TUBA1: Tubulin alpha-4A chain |
ARFGEF2 |
ARFGEF2, ARFGEP2, BIG2: Brefeldin A-inhibited guanine nucleotide-exchange protei |
1.46 |
Evidence |
|